Top Industry Leaders in the Ectropion Market
Latest Ectropion Companies Updates:
August 2023 A study published in the Journal of Ophthalmology found that a new minimally invasive procedure for ectropion repair showed promising results in terms of safety and efficacy. This could lead to increased interest and investment in this area.
July 2023 The American Academy of Ophthalmology released new guidelines for the management of ectropion, which could impact the way doctors treat the condition and potentially influence pharmaceutical or device development.
Morcher GmbH (Austria) Announced the launch of a new line of biocompatible implants for ectropion repair in June 2023.
Merz Pharma (Germany) Received FDA approval for a new injectable filler used for temporary correction of mild to moderate ectropion in May 2023.
List of Ectropion Key companies in the market:
- InSite Vision Incorporated
- NovaBay Pharmaceuticals, Inc.
- Scope Ophthalmics Ltd
- Thea Pharmaceuticals Limited, Perrigo Laboratories
- Merck & Co.
- Gelderma S.A.